<DOC>
	<DOCNO>NCT01234142</DOCNO>
	<brief_summary>This study evaluate steady-state pharmacokinetics , safety tolerability varenicline patch apply daily skin 14 day .</brief_summary>
	<brief_title>A Study Evaluating Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Healthy male female adult cigarette smoker race Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Subjects active suicidal ideation suicidal behavior within 1 year prior Screening determine use CSSRS ( ColumbiaSuicide Severity Rating Scale ) active ideation identify Screening Day 0 . Any condition possibly affect drug absorption skin ( eg , psoriasis ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>varenicline transdermal percutaneous transcutaneous transdermal delivery system patch</keyword>
</DOC>